27.13 USD
-0.39 (-1.42%)
27.13 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to KMTS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.73. This target is 9.57% above the current price.
KMTS was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about KMTS.
In the previous month the buy percentage consensus was at a similar level.
KMTS was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-15 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-12-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-18 | BTIG | Initiate | Buy |
| 2025-07-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-16 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-31 | Wolfe Research | Initiate | Outperform |
| 2025-03-31 | Stifel | Initiate | Buy |
| 2025-03-31 | Wells Fargo | Initiate | Overweight |
| 2025-03-31 | Goldman Sachs | Initiate | Neutral |
| 2025-03-31 | Piper Sandler | Initiate | Overweight |
KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ
What is the average price target for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?
13 analysts have analysed KMTS and the average price target is 29.73 USD. This implies a price increase of 9.57% is expected in the next year compared to the current price of 27.13.
Can you provide the consensus rating for KESTRA MEDICAL TECHNOLOGIES stock?
The consensus rating for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.